Currently, there are 232.45M common shares owned by the public and among those 225.30M shares have been available to trade.
The company’s stock has a 5-day price change of 21.12% and 2.16% over the past three months. ARDX shares are trading 22.10% year to date (YTD), with the 12-month market performance up to 127.33% higher. It has a 12-month low price of $3.16 and touched a high of $10.13 over the same period. ARDX has an average intraday trading volume of 4.98 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 16.31%, 8.11%, and 16.37% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Ardelyx Inc (NASDAQ: ARDX) shares accounts for 61.10% of the company’s 232.45M shares outstanding.
It has a market capitalization of $1.77B and a beta (3y monthly) value of 0.82. The earnings-per-share (ttm) stands at -$0.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.35% over the week and 5.48% over the month.
Earnings per share for the fiscal year are expected to decrease by -14.13%, and 142.16% over the next financial year. EPS should grow at an annualized rate of 30.00% over the next five years, compared to 28.61% over the past 5-year period.
Looking at the support for the ARDX, a number of firms have released research notes about the stock. Leerink Partners stated their Outperform rating for the stock in a research note on April 05, 2024, with the firm’s price target at $14. Raymond James coverage for the Ardelyx Inc (ARDX) stock in a research note released on December 18, 2023 offered a Strong Buy rating with a price target of $12. H.C. Wainwright was of a view on September 07, 2023 that the stock is Buy, while Cantor Fitzgerald gave the stock Overweight rating on August 25, 2023, issuing a price target of $5- $10. Wedbush on their part issued Outperform rating on March 03, 2023.
